Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Composite image showing woman holding award and BHF Fellow of the Year lettering, with heart schematic drawings in background.

Many congratulations to Professor Reilly, who won the award at the British Cardiovascular Society conference on Tuesday 8th June 2021. 

Professor Reilly said "I am hugely honoured to receive this Award from my peers. It is incredibly gratifying and I am so thankful to my colleagues at the British Heart Foundation for this special recognition."

Professor Reilly was awarded an Associate Professorship in Cardiovascular Medicine last year,  and her stand-out recent work includes a Nature paper demonstrating that a hormone that helps helps regulate bone mass is also produced by the heart, and could help treat people with a dangerous heart rhythm disorder. 

We want to hear about your news!

Publishing a paper? Just won an award? Get in touch with communications@rdm.ox.ac.uk

 

Similar stories

COVID-19 patients continue to experience symptoms six months after infection

Study investigating the long-term impact of moderate to severe COVID-19 finds that a large proportion of COVID-19 patients previously admitted to hospital continue to experience intrusive symptoms six months following infection.

RDM researchers awarded Oxford-Bristol Myers Squibb Fellowships

The Oxford - Bristol Myers Squibb (BMS) Fellowships Programme continued to demonstrate significant progress over the last year, despite the challenges associated with the global pandemic, including restricted lab access and work from home guidance. Six new Oxford-BMS Fellowships for 2021 were announced.

Changes in blood cell production over the human lifetime may hold clues to patterns of disease

A new paper published this week in Cell Reports reveals that changes in the gene expression of blood stem cells occur across the human lifetime; an important step in the understanding and treatment of blood disorders.